Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:KIN - BE0974274061 - Common Stock

29.7 EUR
+0.3 (+1.02%)
Last: 12/24/2025, 1:48:25 PM
Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 51 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year KIN was profitable.
In the past year KIN had a positive cash flow from operations.
In multiple years KIN reported negative net income over the last 5 years.
Of the past 5 years KIN 4 years had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 4.54%, KIN is doing good in the industry, outperforming 68.63% of the companies in the same industry.
KIN's Return On Equity of 23.61% is amongst the best of the industry. KIN outperforms 84.31% of its industry peers.
KIN's Return On Invested Capital of 8.28% is fine compared to the rest of the industry. KIN outperforms 72.55% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KIN is below the industry average of 9.50%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a decent Profit Margin value of 7.98%, KIN is doing good in the industry, outperforming 68.63% of the companies in the same industry.
In the last couple of years the Profit Margin of KIN has declined.
With an excellent Operating Margin value of 15.19%, KIN belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
KIN's Operating Margin has declined in the last couple of years.
KIN has a worse Gross Margin (24.54%) than 86.27% of its industry peers.
In the last couple of years the Gross Margin of KIN has declined.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KIN remains at a similar level compared to 1 year ago.
KIN has more shares outstanding than it did 5 years ago.
KIN has a better debt/assets ratio than last year.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that KIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.54, KIN is in line with its industry, outperforming 56.86% of the companies in the same industry.
KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
KIN has a Debt to FCF ratio of 5.38. This is comparable to the rest of the industry: KIN outperforms 47.06% of its industry peers.
KIN has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
KIN has a worse Debt to Equity ratio (2.87) than 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.54
ROIC/WACC1.46
WACC5.68%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.47 indicates that KIN may have some problems paying its short term obligations.
With a Current ratio value of 0.47, KIN is not doing good in the industry: 90.20% of the companies in the same industry are doing better.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.44, KIN is not doing good in the industry: 90.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
The Earnings Per Share has been decreasing by -5.80% on average over the past years.
Looking at the last year, KIN shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
KIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
Based on estimates for the next years, KIN will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.37, which indicates a rather expensive current valuation of KIN.
86.27% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.50. KIN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 11.05, the valuation of KIN can be described as very reasonable.
82.35% of the companies in the same industry are more expensive than KIN, based on the Price/Forward Earnings ratio.
KIN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.93, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.37
Fwd PE 11.05
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KIN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 84.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.22
EV/EBITDA 8.42
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.24% in the coming years.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y26.59%
EPS Next 3Y21.24%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.30%, KIN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.85, KIN pays a bit more dividend than its industry peers.
KIN's Dividend Yield is slightly below the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

KIN pays out 31.09% of its income as dividend. This is a sustainable payout ratio.
DP31.09%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (12/24/2025, 1:48:25 PM)

29.7

+0.3 (+1.02%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)02-20 2026-02-20/amc
Inst Owners17.66%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap812.89M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.35%
PT rev (3m)-0.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.13%
EPS NY rev (3m)-10.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 17.37
Fwd PE 11.05
P/S 1.37
P/FCF 6.22
P/OCF 4.69
P/B 4.06
P/tB 36.27
EV/EBITDA 8.42
EPS(TTM)1.71
EY5.76%
EPS(NY)2.69
Fwd EY9.05%
FCF(TTM)4.77
FCFY16.07%
OCF(TTM)6.34
OCFY21.34%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.76
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.54
F-Score8
WACC5.68%
ROIC/WACC1.46
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


What is the valuation status of KINEPOLIS (KIN.BR) stock?

ChartMill assigns a valuation rating of 7 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What is the earnings growth outlook for KINEPOLIS?

The Earnings per Share (EPS) of KINEPOLIS (KIN.BR) is expected to grow by 22.89% in the next year.


Can you provide the dividend sustainability for KIN stock?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.